HCV therapy and risk of liver cancer recurrence: who to treat?

Colombo Massimo; Boccaccio Vincenzo

首页> 外文期刊>Nature reviews. Gastroenterology & hepatology >HCV therapy and risk of liver cancer recurrence: who to treat?

【24h】

HCV therapy and risk of liver cancer recurrence: who to treat?

机译：HCV治疗与肝癌的风险复发：治疗谁？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Nature reviews. Gastroenterology & hepatology 》 |2018年第7期| 共3页
作者
Colombo Massimo; Boccaccio Vincenzo;
展开▼
作者单位

Humanitas Hosp Ctr Translat Res Hepatol Rozzano Italy;

Humanitas Hosp Ctr Translat Res Hepatol Rozzano Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病 ;
关键词

相似文献

外文文献
中文文献
专利

1. HCV therapy and risk of liver cancer recurrence: who to treat? [J] . Colombo Massimo, Boccaccio Vincenzo Nature reviews. Gastroenterology & hepatology . 2018 ,第7期

机译：HCV治疗与肝癌的风险复发：治疗谁？
2. RENAL DYSFUNCTION IN LIVER TRANSPLANT RECIPENTS TREATED WITH SOFOSBUVIR-BASED THERAPY FOR HCV RECURRENCE: RESULTS FROM THE FRENCH PROSPECTIVE MULTICENTRIC STUDY ANRS CO23 CUPILT [J] . Anty R., Coilly A., Fougerou C., Transplant international : . 2016 ,第Suppla1期

机译：基于SOFOSBUVIR的HCV复发治疗的肝移植受体的肾功能不全：来自法国预期的多中心研究和CO23限制的结果
3. Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: Using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone [J] . GnantM., FilipitsM., GreilR., Annals of oncology: official journal of the European Society for Medical Oncology . 2014 ,第2期

机译：临床病理风险有限的受体阳性乳腺癌患者的远处复发预测：使用ABCSG-8试验的1478名绝经后仅接受辅助内分泌治疗的患者中使用PAM50复发风险评分
4. Profiling a Prophylactic Local Triple Therapy Hydrogel Patch to Treat and Prevent Cancer Recurrence [C] . Natalie Artzi, Joao Conde, Nuria Oliva, Society for Biomaterials annual meeting and exposition . 2017

机译：对预防性局部三联疗法水凝胶补丁进行概要分析，以治疗和预防癌症复发
5. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
6. Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus (HCV) Liver Transplant Recipients Treated with Pretransplant Direct-Acting Antiviral (DAA) Therapy [O] . Nicholas Lim, Dupinder Singh, Scott Jackson, 2020

机译：丙型肝炎病毒（HCV）肝移植受者的肝细胞癌复发用预体直接作用抗病毒（DAA）治疗治疗
7. Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus (HCV) Liver Transplant Recipients Treated with Pretransplant Direct-Acting Antiviral (DAA) Therapy [O] . Nicholas Lim, Dupinder Singh, Scott Jackson, 2020

机译：丙型肝炎病毒（HCV）肝移植受者的肝细胞癌复发，用预体直接作用抗病毒（DAA）治疗治疗
8. Pilot Study Testing the Technical Feasibility and Toxicity of High Dose Rate Brachytherapy Combined with Hyperthermia to Treat Prostate Cancer Recurrences after External Beam Irradiation or Permanent Seed Implant Failure [R] . Corry, P. M. , Martinez, A. 2004

机译：试验研究测试高剂量率近距离放射治疗联合热疗的技术可行性和毒性，以治疗外照射或永久性种子植入失败后的前列腺癌复发

HCV therapy and risk of liver cancer recurrence: who to treat?

著录项

相似文献

相关主题

期刊订阅